Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Indian J Surg Oncol ; 14(1): 169-175, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36891438

ABSTRACT

Renal tumors in young population are relatively rare. We reviewed our experience with renal masses in patients below 45 years of age. Our objective was to analyze clinico-pathological and survival characteristics of renal malignancy in young adults in contemporary era. The medical records of patients below 45 years of age who underwent surgery for renal mass at our tertiary care center between 2009 and 2019 were retrospectively analyzed. Pertinent clinical information was compiled, including age, gender, year and type of surgery, histopathology and survival data. A total of 194 patients who underwent nephrectomy for suspicious renal masses were included. Mean age was 35.5 (14-45) years and males were 125 (64.4%). A total of 29/198 (14.6%) specimens had benign disease. In addition, 155 (91.7%) out of 169 malignant tumors were renal cell carcinomas, clear cell variant being the most common type (51%). Compared to RCC, non-RCC tumors were more common in females (27.7 vs 78.6%, p < 0.0001), had an early age of diagnosis (27.2 vs 36.9 year, p < 0.00001) and poorer progression-free (58.3 vs 72.0%, p = 0.03) and overall survival (63.6 vs 84.2%, p = 0.02) at 6 years of follow-up. Renal masses in young adults are most commonly RCC but can also include other diverse types. RCC in young adults is usually organ confined and has good prognosis. As compared to RCC, non-RCC malignant tumors occur in young age, are more in females, and have worse prognosis. Supplementary Information: The online version contains supplementary material available at 10.1007/s13193-022-01643-2.

2.
BMJ Case Rep ; 13(12)2020 Dec 22.
Article in English | MEDLINE | ID: mdl-33370975

ABSTRACT

A 52-year-old man presented with lower urinary tract symptoms and intermittent haematuria for the last 6 months. He had undergone totally extraperitoneal right inguinal hernia repair a decade ago. The ultrasonography and an X-ray of the pelvis suggested a large radio-opaque shadow in the bladder. However, CT revealed an encrusted intravesical extension of the migrated mesh along the right anterolateral wall. The entire intravesical part of the migrated mesh with encrustations was successfully retrieved by endourological approach using holmium laser. The patient symptomatically improved and at follow-up, cystoscopy showed a complete re-epithelisation of the bladder mucosa. The intravesical extension of migrated mesh is a rare but challenging complication following mesh hernioplasty and can be successfully managed with a complete endoscopic approach.


Subject(s)
Device Removal/methods , Foreign-Body Migration/surgery , Herniorrhaphy/adverse effects , Lasers, Solid-State/therapeutic use , Prosthesis Failure , Surgical Mesh/adverse effects , Cystoscopy , Device Removal/instrumentation , Foreign-Body Migration/complications , Foreign-Body Migration/diagnosis , Hematuria/diagnosis , Hematuria/etiology , Hematuria/surgery , Hernia, Inguinal/surgery , Herniorrhaphy/instrumentation , Humans , Lower Urinary Tract Symptoms/diagnosis , Lower Urinary Tract Symptoms/etiology , Lower Urinary Tract Symptoms/surgery , Male , Middle Aged , Tomography, X-Ray Computed , Ultrasonography , Urinary Bladder/diagnostic imaging , Urinary Bladder/surgery
3.
J Egypt Natl Canc Inst ; 32(1): 40, 2020 Oct 12.
Article in English | MEDLINE | ID: mdl-33043406

ABSTRACT

BACKGROUND: Primary malignant melanoma of the female urethra is an exceedingly rare tumor. It represents 0.2% of all malignant melanomas. Divergent differentiation towards non-melanocytic lineages has not been reported in urethral melanoma. CASE PRESENTATION: We report a rare case of neuroendocrine differentiation in a large primary small cell malignant melanoma involving the urethra, in a 62-year-old lady, who presented with obstructive urinary symptoms. Clinical and radiological workup revealed a large urethral mass with liver and lymph nodal metastases. A biopsy was performed from the urethral and liver lesions which showed poorly differentiated tumor cells with small cell morphology and presence of melanin pigment. These cells were immunopositive for melanocytic and neuroendocrine markers. Ultrastructural examination showed presence of melanosomes and neurosecretory granules in the tumor cells. CONCLUSIONS: Although malignant melanoma with neuroendocrine differentiation is exceptionally rare, it needs to be recognized among the other well-known variants of malignant melanoma.


Subject(s)
Melanoma , Urethral Neoplasms , Cell Differentiation , Female , Humans , Lymphatic Metastasis , Melanoma/diagnosis , Middle Aged , Urethral Neoplasms/diagnosis
4.
BMJ Case Rep ; 13(6)2020 Jun 30.
Article in English | MEDLINE | ID: mdl-32606127

ABSTRACT

A 30-year-old woman presented with vesicovaginal fistula after a forceful intercourse. She was diagnosed as a case of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome 14 years ago and had underwent McIndoe's vaginoplasty using amniotic membrane. Similarly, another 14-year-old girl presented with an iatrogenic urethral and bladder neck injury during an attempt at McIndoe's vaginoplasty 4 months ago at another centre leading to urinary fistula with absent vagina. A laparoscopic salvage was done for both the cases along with repair of genitourinary fistula using sigmoid colon. There was no further requirement of vaginal dilation. Both patients remain fully continent at 1 year follow-up. Laparoscopic sigmoid vaginoplasty is a worthy minimally invasive salvage method for the patients of MRKH who develop fistulous complication after a previous attempt at neovagina creation. The bowel wall provides a structurally strong layer to withstand the repeated sexual trauma of the vagina.


Subject(s)
46, XX Disorders of Sex Development , Colon, Sigmoid/surgery , Congenital Abnormalities , Gynecologic Surgical Procedures , Intraoperative Complications/surgery , Mullerian Ducts/abnormalities , Urethra , Urinary Bladder , Vagina , Vesicovaginal Fistula , 46, XX Disorders of Sex Development/diagnosis , 46, XX Disorders of Sex Development/surgery , Adolescent , Adult , Congenital Abnormalities/diagnosis , Congenital Abnormalities/surgery , Female , Gynecologic Surgical Procedures/adverse effects , Gynecologic Surgical Procedures/methods , Humans , Intraoperative Complications/diagnosis , Laparoscopy/methods , Mullerian Ducts/surgery , Plastic Surgery Procedures/methods , Reoperation/methods , Salvage Therapy/methods , Surgically-Created Structures , Treatment Outcome , Urethra/injuries , Urethra/surgery , Urinary Bladder/injuries , Urinary Bladder/surgery , Vagina/abnormalities , Vagina/surgery , Vesicovaginal Fistula/diagnosis , Vesicovaginal Fistula/etiology , Vesicovaginal Fistula/surgery
5.
Sci Rep ; 10(1): 3585, 2020 02 27.
Article in English | MEDLINE | ID: mdl-32108161

ABSTRACT

Office cystoscopy may be associated with urinary tract infection (UTI) in up to 10-20% of patients. Current practice of surgical part preparation in males with povidone-iodine excludes distal urethra in males, leaving a possibility for resident intra-urethral flora to cause post-procedural UTI. We designed this randomized study to assess whether additional cleaning of distal urethra with povidone-iodine solution can help reduce post-procedural incidence of UTIs in this setting. Additionally, urethral swab culture was done in the entire cohort to identify the prevalent microflora in the distal male urethra and to evaluate its role in causation of post-procedural UTI. Using a specialized urethral swab culture methodology, 85% males demonstrated some bacteria and 16% showed common uro-pathogens. 28 (14.5%) cases had post-procedure culture positive UTI. The incidence of UTI in control group (22%) was significantly more than the intervention group (7%) (p value <0.007). This result strongly supports inclusion of distal urethral irrigation with povidone-iodine in males before office cystoscopy, even when pre-procedure mid-stream urine culture is sterile.


Subject(s)
Cystoscopy/adverse effects , Povidone-Iodine/administration & dosage , Urethra/microbiology , Urinary Tract Infections/prevention & control , Adolescent , Adult , Aged , Bacteria/classification , Bacteria/drug effects , Bacteria/genetics , Bacteria/isolation & purification , Cohort Studies , Humans , Male , Middle Aged , Urethra/drug effects , Urinary Tract Infections/etiology , Urinary Tract Infections/microbiology , Young Adult
6.
BMJ Case Rep ; 12(11)2019 Nov 19.
Article in English | MEDLINE | ID: mdl-31748356

ABSTRACT

Neuroendocrine tumour (NET) of the urinary bladder (UB) is a rare entity and comprises of well-differentiated, small cell and large cell types. Small and large cell NET like that in lung and gastrointestinal tract have an aggressive nature and are considered high-grade disease. Well-differentiated NET has been thought to be localised and having a good prognosis. We report the first case of metastatic well-differentiated NET of the UB. Our case is a 44-year-old man with well-differentiated NET of UB presented with hepatic and peritoneal metastases on initial diagnosis. He was treated with metaiodobenzylguanidine (MIBG) therapy and had a modest survival of 16 months. The primary well-differentiated NETs can present as a metastatic disease with an aggressive nature. MIBG therapy can be considered as a useful option but overall prognosis is poor. Further research is needed for better understanding and better treatment protocol.


Subject(s)
Neuroendocrine Tumors/drug therapy , Neuroendocrine Tumors/secondary , Urinary Bladder/pathology , 3-Iodobenzylguanidine/administration & dosage , 3-Iodobenzylguanidine/therapeutic use , Administration, Intravenous , Adult , Cell Differentiation , Diagnosis, Differential , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/therapeutic use , Humans , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Male , Neoplasm Metastasis/pathology , Neuroendocrine Tumors/pathology , Neuroendocrine Tumors/ultrastructure , Peritoneal Neoplasms/pathology , Peritoneal Neoplasms/secondary , Treatment Outcome , Urinary Bladder/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...